Medicine Description ipradol 0.5mg
Ipradol 0.5mg Tablets is a medication that primarily functions as a beta-2 adrenergic agonist. By selectively stimulating beta-2 adrenergic receptors in the uterus, it promotes the relaxation of uterine smooth muscle. This effect is mediated through an increase in cyclic AMP (cAMP) levels, leading to inhibition of myosin light chain kinase, which is responsible for muscle contraction. Consequently, Ipradol effectively reduces uterine contractions, making it beneficial in managing premature labor and other obstetric conditions requiring uterine relaxation.
Indications and Uses of Ipradol 0.5mg Tablets
- Prevention of premature labor in high-risk situations.
- Loading dose administration for rapid therapeutic drug levels prior to intravenous infusion during premature labor management.
- Rapid alleviation of hypertonic uterine activity associated with oxytocic agents during labor induction.
- Temporary intervention for fetal distress prior to imminent vaginal delivery or cesarean section.
- Quick cessation of uterine contractions prior to cesarean delivery in cases of umbilical cord prolapse.
- Facilitating external cephalic version in cases of an irritable uterus.
- Management of uterine activity when oxytocic medications have been mistakenly administered.
Side Effects of Ipradol 0.5mg Tablets
- Tachycardia (increased heart rate).
- Tremors or jitteriness.
- Headache.
- Palpitations.
- Hypokalemia (low potassium levels).
- Nausea or vomiting.
- Hyperglycemia (increased blood sugar levels).
Storage and Handling
Store Ipradol 0.5mg Tablets at room temperature, away from moisture and light. Ensure it is kept out of reach of children and pets. Do not use any expired medication.
Patient Advice and Precautions
Patients should be advised to inform their healthcare provider of any existing medical conditions or medications they are currently taking, particularly those affecting cardiovascular function. It is crucial to monitor for any side effects or unusual symptoms while on this medication, and to avoid sudden discontinuation without consulting a healthcare professional.